Information for Clinicians

About Blood Cancer Network Ireland

Where we began

In 2015 a 5-year €2.3million grant (+ industry funds) was awarded in a competitive grant process to the BCNI from SFI and the Irish Cancer Society. Additional funding from the Irish Cancer Society is being made available to extend the network with the Mater and Beaumont hospitals as associate members.

1 A national early phase (phase 1b) clinical trials network will be established with a single quality system, management system and progression path designed to ensure that Irish patients will benefit from potentially beneficial new cancer therapies at an early stage. It will be attractive for pharma to have a single national contact centre giving access to sites in Dublin, Galway and Cork. The early phase cancer trials network will work closely with Cancer Trials Ireland and any non – Cancer Trials Ireland sponsored studies will be mentioned at DSSG and publicized so that patients in any hospital can benefit from referral. 

2 Bio-banking for blood cancers. Initial funding will be used for collecting samples on newly diagnosed myeloma and AML patients. The initial funding allows for collection of samples in NUIG, TCD and UCC associated hospitals. It is anticipated that the successful start up of this bio-banking will attract further funding to allow bio-banking for all blood cancers.

3. Enhanced cancer registration. The National Cancer registry has been funded to recruit and train additional Tumor Registration Officers (TRO) to collect data that is relevant to prognosis, management, therapy and outcome. It is also planned to undertake patient reported outcomes measures (PROMs) studies.

Where we hope to be in 5 years time

1 A national early phase (phase 1b) clinical trials network. Trials up and running with tight control on management of adverse events supported by a healthy inter-hospital referral network involving every haematologist in the country.

2 Bio-banking for blood cancers. All new blood cancers in all hospitals being collected for a national biobank with funded support for every haematology unit. BCNI will work to seek additional funding for this.

3. Enhanced cancer registration. All blood cancers in all sites undergoing enhanced cancer registration in the NCRI. 

For information on open and upcoming Clinical Trials please see our Clinical Trials page